Growth Metrics

Neuraxis (NRXS) Asset Writedowns and Impairment (2022 - 2025)

Neuraxis (NRXS) has disclosed Asset Writedowns and Impairment for 4 consecutive years, with -$22013.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 39.67% to -$22013.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$23021.0 through Dec 2025, down 411.3% year-over-year, with the annual reading at $2326.0 for FY2025, 68.55% down from the prior year.
  • Asset Writedowns and Impairment hit -$22013.0 in Q4 2025 for Neuraxis, down from $11598.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $21307.0 in Q2 2022 to a low of -$23290.0 in Q4 2022.
  • Historically, Asset Writedowns and Impairment has averaged $2576.4 across 4 years, with a median of $6367.0 in 2024.
  • Biggest YoY gain for Asset Writedowns and Impairment was 460.02% in 2024; the steepest drop was 183.39% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at -$23290.0 in 2022, then surged by 181.16% to $18901.0 in 2023, then crashed by 183.39% to -$15761.0 in 2024, then tumbled by 39.67% to -$22013.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for NRXS at -$22013.0 in Q4 2025, $11598.0 in Q3 2025, and -$15761.0 in Q4 2024.